Renal denervation device firm obtains $2.7M

08/16/2013 | MassDevice.com (Boston)

Ablative Solutions has secured $2.7 million from 41 undisclosed backers, part of a funding round aiming for $5 million. The company, with offices in Michigan and California, is working on a perivascular renal denervation device that can be used to treat patients with high blood pressure by delivering radio-frequency energy straight to the nerves.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX